Sarclisa Escena FDA Approval: Sanofi Transforms Multiple Myeloma...

a adăugat un sunet Health

2026-09-09 11:45:04 -

Sarclisa Escena FDA Approval: Sanofi Transforms Multiple Myeloma Treatment Delivery

Sarclisa Escena Advances Multiple Myeloma Treatment Convenience Sanofi has reached an important milestone in multiple myeloma treatment with Sarclisa Escena, a subcutaneous version of isatuximab-irfc designed for administration using the CirCLIQ on-body injector. The U.S. Food and Drug Administration granted approval on July 9, 2026, marking the first authorization of an anticancer therapy...

0 Commentarii 0 Distribuiri 2 Views 0 previzualizare